ROBIN PINTO's most recent trade in Glenmark Pharmaceuticals Ltd. was a Acquisition of 250 Equity Shares done at an average price of Rs. 490.2 . Disclosure was reported to the exchange on Nov. 24, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for ROBIN PINTO in the Trendlyne database.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glenmark Pharma | ROBIN PINTO | Promoter Group | Acquisition | 24 Nov 2021 | 250 | 497,500 (0.18%) | 0.00% | 490.2 | 122,548 | 23 Nov 2021 23 Nov 2021 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | ROBIN PINTO | Promoter Group | Acquisition | 28 Sep 2020 | 250 | 496,500 (0.18%) | 0.00% | 451.3 | 112,832 | 24 Sep 2020 24 Sep 2020 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | ROBIN PINTO | Promoter Group | Acquisition | 23 Sep 2020 | 250 | 496,250 (0.18%) | 0.00% | 465.0 | 116,254 | 22 Sep 2020 22 Sep 2020 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | ROBIN PINTO | Promoter Group | Acquisition | 07 Sep 2020 | 500 | 496,000 (0.18%) | 0.00% | 479.4 | 239,705 | 01 Sep 2020 01 Sep 2020 |
Insider Trading | Equity Shares | Market Purchase |
Glenmark Pharma | ROBIN PINTO | Promoter Group | Acquisition | 31 Aug 2020 | 500 | 495,500 (0.18%) | 0.00% | 500.5 | 250,236 | 27 Aug 2020 27 Aug 2020 |
Insider Trading | Equity Shares | Market Purchase |